Choline Fenofibrate - CAS# 856676-23-8 A-767491 even when administered up to

even when administered up to 48 hours after infection

40)47)41(46)52-32-20-31(16-15-25(2)38(24)53-35-21-34(49-6)37(45)28(5)51-35)54-42(22-32)18-17-26(3)39(55-42)29-12-8-7-9-13-29/h10-11

4-dichlorophenyl)ethyl]-4-methyl-piperazine

¹⁹]icosa-1(20)

Madiraju P

Choline Fenofibrate - CAS# 856676-23-8 A-767491 even when administered up toCholine fenofibrate, also known as ABT 335 or fenofibric acid, a lipid regulating agent available as delayed release capsules for oral administration. The lipid modifying effects of fenofibric acid seen in clinical practice have been explained in vivo in transgenic mice and in vitro in human hepatocyte cultures by the activation of peroxisome proliferator activated receptor (PPAR). Through this mechanism, fenofibric acid increases lipolysis and